LONGBOAT KEY, FL, June 10, 2026 (GLOBE NEWSWIRE) — Rumble Inc. (NASDAQ: RUM) (“Rumble” or the “Company”), the Freedom-First technology platform, today announced that its management team will participate in the following upcoming conferences:
ZOOZ Strategy Announces Review and Evaluation of Strategic Alternatives to Complement Bitcoin Strategy
TEL AVIV, Israel, June 10, 2026 (GLOBE NEWSWIRE) — ZOOZ Strategy Ltd. (Nasdaq and TASE: ZOOZ) (“ZOOZ” or the “Company”) today announced that its Board of Directors has authorized management to explore a range of strategic alternatives that could potentially complement the Company’s existing bitcoin treasury strategy and enhance long-term shareholder value.
Solidion Technology Announces Closing of $35 Million Private Placement of Common Stock Priced Above Market Under Nasdaq Rules
Proceeds fully fund the company through 2028 and will be used to accelerate commercialization of Solidion’s patented Extreme-Climate Battery Technology targeting the Lunar economy and space applications
VERAXA Biotech to Debut as a Publicly Traded Company Pioneering Next-Generation Cancer Therapies on June 11, 2026
Quantum SPACs Are Back. Should IONQ, QBTS, and RGTI Investors Be Excited or Worried? – TipRanks
Quantum SPACs Are Back. Should IONQ, QBTS, and RGTI Investors Be Excited or Worried? TipRanks
The Debate-Loving German Telecom Exec Plotting a Blockbuster Merger
Phemex Enhances Prediction Markets with Strategic Navigation and Curated Event Discovery
APIA, Samoa, June 10, 2026 (GLOBE NEWSWIRE) — Phemex, a user-first crypto exchange,has announced a significant upgrade to its Prediction Markets platform, introducing advanced features designed to streamline the intersection of information and execution. As global markets and sporting events become increasingly complex, Phemex is refining how its 10 million users interact with real-world outcomes, ensuring that every participant can navigate high-stakes events with greater precision and structural clarity.

Phemex Enhances Prediction Markets with Strategic Navigation and Curated Event Discovery
APIA, Samoa, June 10, 2026 (GLOBE NEWSWIRE) — Phemex, a user-first crypto exchange,has announced a significant upgrade to its Prediction Markets platform, introducing advanced features designed to streamline the intersection of information and execution. As global markets and sporting events become increasingly complex, Phemex is refining how its 10 million users interact with real-world outcomes, ensuring that every participant can navigate high-stakes events with greater precision and structural clarity.

Visionary Holdings Inc.Receives Nasdaq Staff Determination Letter and Intends to Request a Hearing
Toronto, June 10, 2026 (GLOBE NEWSWIRE) — On June 9, 2026, Visionary Holdings Inc. (the “Company”, Nasdaq ticker: GV) announced that on June 4, 2026, it received a Staff Determination Letter from the Nasdaq Listing Qualifications Department, in which Nasdaq regulatory staff formally determined to delist the Company’s securities.
Luxury meets legacy: ORO Hotel & Residences partners with Ron del Barrilito to create Signature Barrilito Bar
The bar will be one of many amenities at the condo-residence hotel that will redefine luxury living in the heart of San Juan’s Financial District
Splashtop Earns 2026 Top Rated Award from TrustRadius
Customer feedback highlights strong performance, security, user experience, and support across IT teams and MSPs
Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight
The metastatic prostate cancer market is undergoing a major transition from conventional ADT toward combination-based, biomarker-driven, and precision-targeted treatment approaches. While AR pathway inhibitors continue to dominate across mHSPC and mCRPC settings, the emergence of novel therapies such as 225Ac PSMA 617 (Novartis), 177Lu-DOTA-rosopatamab (TLX591) (Telix Pharmaceuticals), Azetukalner (XEN1101) (Xenon Pharmaceuticals), Mevrometostat (PF-06821497) (Pfizer), Cabozantinib (CABOMETYX, XL184) (Exelixis, Ipsen Pharma, and Takeda), and others is significantly reshaping the treatment paradigm.
Lupus Nephritis Clinical Trial Landscape Becomes Increasingly Crowded with 30+ Pharma Companies | DelveInsight
The lupus nephritis clinical trial analysis report delivers important insights into ongoing research of 35+ pipeline lupus nephritis drugs, clinical strategies, upcoming therapeutics, and commercial analysis.
Credyt Launches AI-First Billing, Letting Builders Add Usage-Based Billing in a Single Prompt
As vibe coding turns millions of non-engineers into AI founders, Credyt brings real-time, usage-based billing directly into the tools they already build in.
AEM United States Ag Tractor and Combine Report | May 2026
Milwaukee, June 10, 2026 (GLOBE NEWSWIRE) —
FASTECH and Bosch Rexroth to Build World’s Largest Hydrogen Refueling Station for Transit Buses
San Mateo County, California, USA, June 10, 2026 (GLOBE NEWSWIRE) — FASTECH, in collaboration with Bosch Rexroth, announced that they have been contracted by the San Mateo County Transit District (SamTrans) to design, build, and commission a large-scale hydrogen refueling station, featuring Bosch Rexroth’s innovative CryoPump system technology to support transit bus operations.
Teva Closes Acquisition of Emalex Biosciences, Strengthening Late-Stage Neuroscience Pipeline and Advancing Pivot to Growth Strategy
TEL AVIV, Israel, June 10, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the closing of Teva’s acquisition of Emalex Biosciences, strengthening its late-stage pipeline with ecopipam and further advancing its Pivot to Growth strategy. Phase 3 data for ecopipam were recently published in JAMA Neurology, and a U.S. NDA submission is anticipated in the second half of 2026.